Volatile compounds emission from teratogenic human pluripotent stem cells observed during their differentiation in vivo

[1]  G. Tonini,et al.  Short-term benefit of smoking cessation along with glycopirronium on lung function and respiratory symptoms in mild COPD patients: a retrospective study , 2018, Journal of breath research.

[2]  R. Mango,et al.  Modelling the pathogenesis of Myotonic Dystrophy type 1 cardiac phenotype through human iPSC-derived cardiomyocytes. , 2018, Journal of molecular and cellular cardiology.

[3]  R. Capuano,et al.  GC/MS-based Analysis of Volatile Metabolic Profile Along in vitro Differentiation of Human Induced Pluripotent Stem Cells. , 2017, Bio-protocol.

[4]  R. Capuano,et al.  A preliminary analysis of volatile metabolites of human induced pluripotent stem cells along the in vitro differentiation , 2017, Scientific Reports.

[5]  R. Correa,et al.  Volatile organic compounds associated with Plasmodium falciparum infection in vitro , 2017, Parasites & Vectors.

[6]  R. Pereiro,et al.  Exhaled breath and oral cavity VOCs as potential biomarkers in oral cancer patients , 2017, Journal of breath research.

[7]  R. Paolesse,et al.  Porphyrinoids for Chemical Sensor Applications. , 2017, Chemical reviews.

[8]  Heather D. Bean,et al.  Comparative analysis of the volatile metabolomes of Pseudomonas aeruginosa clinical isolates , 2016, Journal of breath research.

[9]  T. Walles,et al.  Comparison of volatile organic compounds from lung cancer patients and healthy controls—challenges and limitations of an observational study , 2016, Journal of breath research.

[10]  Roberto Paolesse,et al.  An Exploration of the Metal Dependent Selectivity of a Metalloporphyrins Coated Quartz Microbalances Array , 2016, Sensors.

[11]  K. Unterkofler,et al.  A Compendium of Volatile Organic Compounds (VOCs) Released By Human Cell Lines , 2016, Current medicinal chemistry.

[12]  R. Capuano,et al.  The lectin-like oxidized LDL receptor-1: a new potential molecular target in colorectal cancer , 2016, Oncotarget.

[13]  Hossam Haick,et al.  Detection of cancer through exhaled breath: a systematic review , 2015, Oncotarget.

[14]  F. Brancati,et al.  Generation of Human Induced Pluripotent Stem Cells from Extraembryonic Tissues of Fetuses Affected by Monogenic Diseases. , 2015, Cellular reprogramming.

[15]  Joseph C. Wu,et al.  Teratoma formation: a tool for monitoring pluripotency in stem cell research. , 2015, Current protocols in stem cell biology.

[16]  Wei Zhang,et al.  Assessment of ovarian cancer conditions from exhaled breath , 2015, International journal of cancer.

[17]  H. Haick,et al.  Analysis of exhaled breath for diagnosing head and neck squamous cell carcinoma: a feasibility study , 2014, British Journal of Cancer.

[18]  R. Capuano,et al.  Volatile Emissions from Compressed Tissue , 2013, PloS one.

[19]  Peter J. Sterk,et al.  Volatile Metabolites of Pathogens: A Systematic Review , 2013, PLoS pathogens.

[20]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[21]  N. Benvenisty,et al.  The tumorigenicity of human embryonic and induced pluripotent stem cells , 2011, Nature Reviews Cancer.

[22]  Bogusław Buszewski,et al.  Determination of volatile organic compounds in human breath for Helicobacter pylori detection by SPME-GC/MS. , 2011, Biomedical chromatography : BMC.

[23]  Jarrett Rosenberg,et al.  Single cell transcriptional profiling reveals heterogeneity of human induced pluripotent stem cells. , 2011, The Journal of clinical investigation.

[24]  Olaf Tietje,et al.  Differential Volatile Signatures from Skin, Naevi and Melanoma: A Novel Approach to Detect a Pathological Process , 2010, PloS one.

[25]  Pablo Menendez,et al.  Human Induced Pluripotent Stem Cells Develop Teratoma More Efficiently and Faster Than Human Embryonic Stem Cells Regardless the Site of Injection , 2010, Stem cells.

[26]  F. Müller,et al.  A call to standardize teratoma assays used to define human pluripotent cell lines. , 2010, Cell stem cell.

[27]  H. Haick,et al.  Diagnosing lung cancer in exhaled breath using gold nanoparticles. , 2009, Nature nanotechnology.

[28]  Hideyuki Okano,et al.  Variation in the safety of induced pluripotent stem cell lines , 2009, Nature Biotechnology.

[29]  Moustapha Kassem,et al.  Teratoma formation by human embryonic stem cells is site dependent and enhanced by the presence of Matrigel. , 2009, Stem cells and development.

[30]  Ahmad Y. Sheikh,et al.  Spatial and temporal kinetics of teratoma formation from murine embryonic stem cell transplantation. , 2007, Stem cells and development.

[31]  Ping Wang,et al.  A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis , 2007, Cancer.

[32]  I. Jolliffe.  Principal Component Analysis , 2005 .

[33]  H. Norris,et al.  Immature (malignant) teratoma of the ovary. A clinical and pathologic study of 58 cases , 1976, Cancer.

[34]  Hossam Haick,et al.  Breath testing as potential colorectal cancer screening tool , 2016, International journal of cancer.

[35]  Wendy Y. Zhang.  Teratoma formation: A tool for monitoring pluripotency in stem cell research , 2014 .

[36]  E. Ohno,et al.  Tumorigenesis in cells derived from induced pluripotent stem cells , 2013, Human Cell.

[37]  Tomas Mikoviny,et al.  Release of volatile organic compounds from the lung cancer cell line NCI-H2087 in vitro. , 2009, Anticancer research.

[38]  J. Affeldt,et al.  The feasibility study , 2019, The Information System Consultant’s Handbook.